Mighty Oak Medical and Medacta Announce Non-Exclusive Worldwide License to Patents for Patient-Specific Pedicle Screw Guides

PRESS RELEASE

Mighty Oak Medical and Medacta Announce Non-Exclusive Worldwide License to Patents for Patient-Specific Pedicle Screw Guides

Englewood, CO & Franklin, TN, August 28, 2024 — Mighty Oak Medical, Inc., Medacta USA, Inc. and Medacta International SA today announced that they have entered into a settlement and license agreement resolving the patent litigation between the companies.

Under the agreement, Medacta receives a non-exclusive license to Mighty Oak’s patents relating to patient-specific pedicle screw guides for use in adult spinal surgery.

Medacta has agreed to sell its MySpine Guides worldwide for exclusive use with Medacta pedicle screws through 2031.

“We are pleased to have resolved the ongoing litigation with Medacta and are excited to refocus all internal resources on developing next-generation preoperative planning and patient-specific solutions to improve patient care,” said Nick Byrne, VP Sales & Marketing at Mighty Oak Medical.

About Mighty Oak Medical

Mighty Oak Medical is a commercial-stage medical device development company focused on patient-specific solutions to make complex spine surgeries safer and more efficient. Founded in 2011 in Englewood, Colorado, Mighty Oak specializes in 3D pre-surgical planning, 3D printing, and AI-driven software development. The award-winning FIREFLY^® Technology is used worldwide from C1 to the pelvis to achieve unmatched accuracy in the most challenging spinal deformity and revision surgeries in children and adults, all without the need for intraoperative radiation.

www.mightyoakmedical.com

About Medacta

Medacta is a major global player specializing in the design, manufacturing and distribution of innovative, personalized and sustainable solutions for joint replacement, sports medicine and spine surgery. Founded in 1999 in Switzerland, Medacta is committed to improving the care and well-being of patients. The company is strongly focused on the sustainability of healthcare. Through close collaboration with expert surgeons worldwide, continuous investment in R&D and the adoption of advanced technologies, Medacta’s innovation prioritizes minimally invasive surgery and personalized solutions for each patient. Through the MORE Institute, Medacta supports surgeons with a comprehensive and customized program focused on the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in more than 60 countries. Follow us on Medacta TV, YouTube, LinkedIn and X.